Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Yervoy | ipilimumab | Bristol Myers Squibb | N-125377 RX | 2011-03-25 | 2 products |
Brand Name | Status | Last Update |
---|---|---|
yervoy | Biologic Licensing Application | 2025-05-28 |
Expiration | Code | ||
---|---|---|---|
ipilimumab, Yervoy, Bristol-Myers Squibb Company | |||
2027-10-02 | Orphan excl. |
Code | Description |
---|---|
J9228 | Injection, ipilimumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | 2 | 15 | 4 | 1 | 6 | 27 |
Lung neoplasms | D008175 | — | C34.90 | 7 | 9 | 3 | 1 | 2 | 18 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 2 | 2 | 1 | 1 | 2 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 31 | 55 | 12 | — | 23 | 111 |
Neoplasms | D009369 | — | C80 | 26 | 37 | 1 | — | 1 | 47 |
Non-small-cell lung carcinoma | D002289 | — | — | 11 | 24 | 7 | — | 6 | 40 |
Prostatic neoplasms | D011471 | — | C61 | 3 | 18 | 3 | — | — | 21 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 7 | 10 | 2 | — | — | 16 |
Colorectal neoplasms | D015179 | — | — | 6 | 9 | 1 | — | — | 12 |
Small cell lung carcinoma | D055752 | — | — | 3 | 8 | 1 | — | — | 10 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | 7 | 1 | — | — | 10 |
Carcinoma | D002277 | — | C80.0 | 3 | 3 | 1 | — | 5 | 9 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 5 | 4 | 2 | — | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 6 | 9 | — | — | — | 12 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 8 | — | — | 1 | 10 |
Transitional cell carcinoma | D002295 | — | — | 5 | 7 | — | — | — | 9 |
Cutaneous malignant melanoma | D000096142 | — | — | 4 | 4 | — | — | 1 | 8 |
Urologic neoplasms | D014571 | — | C64-C68 | 5 | 5 | — | — | — | 7 |
Urinary bladder neoplasms | D001749 | — | C67 | 4 | 4 | — | — | — | 6 |
Malignant mesothelioma | D000086002 | — | — | 1 | 4 | — | — | 2 | 6 |
Multiple myeloma | D009101 | — | C90.0 | 3 | 4 | — | — | — | 5 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 2 | 3 | — | — | — | 5 |
Uveal neoplasms | D014604 | EFO_1001230 | — | 1 | 4 | — | — | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | — | — | — | — | 1 |
Nerve sheath neoplasms | D018317 | EFO_0000760 | — | 1 | — | — | — | — | 1 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | — | — | — | 1 |
Hiv-2 | D015498 | — | — | 1 | — | — | — | — | 1 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 1 | — | — | — | — | 1 |
Fallopian tube diseases | D005184 | EFO_0009548 | N83 | 1 | — | — | — | — | 1 |
Laryngeal diseases | D007818 | — | J38.7 | 1 | — | — | — | — | 1 |
Laryngitis | D007827 | — | — | 1 | — | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
Gata2 deficiency | D000077428 | — | D46.22 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatitis c | D006526 | — | B19.2 | — | — | — | — | 1 | 1 |
Hepatitis b | D006509 | — | — | — | — | — | — | 1 | 1 |
Hepatitis | D006505 | — | K75.9 | — | — | — | — | 1 | 1 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | — | — | 1 | 1 |
Drug common name | Ipilimumab |
INN | ipilimumab |
Description | Ipilimumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | >7SU0:H,I|Fab heavy chain
(PCA)VQLVESGGGVVQPGRSLRLSCAASGFTFSHYTMHWVRQAPGKGLEWVTFISYDGHNKYYADSVKGRFTISRDNSK
NTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVT
VSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCGGHHHHHH
>7SU0:L,M|Fab light chain
EIVLTQSPGTLSLSPGERATLSCRASQEVGESELAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLE
PEDFAVYYCQQYGSSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNS
QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 5TRU, 5XJ3, 6JC2, 6RP8, 7SU0, 7SU1 |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1789844 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB06186 |
UNII ID | 6T8C155666 (ChemIDplus, GSRS) |